Review Article

Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential

Table 2

Summary of lncRNAs and circRNAs involved in the metabolic reprogramming of LC as potential diagnostic or/and prognostic biomarkers.

lncRNA/circRNADeregulationDetection methodSample type and the number of samplesSurvival analysis and the number of patients enrolledSurvival outcomes correlated with the expressionClinical characteristics associated with the expressionBiomarker categoryReference

DUXAP8RT-qPCRLC tissues; 66OS; 66Poor survival outcomeTNM stage, LNMDiagnosis/prognosis[22]
IGFBP4-1RT-qPCRLC tissues; 159TNM stageDiagnosis[23]
BCYRN1RT-qPCRLC tissues; 20Diagnosis[25]
CRYBG3RT-qPCRLC tissues; 23Distant metastasisDiagnosis[28]
LINC00243RT-qPCRLC tissues; 59 from TCGA database and 70 from the patients enrolledOS; 70Poor survival outcomeDiagnosis/prognosis[34]
AC020978FISH, RT-qPCRLC tissues; 92(FISH), 16(RT-qPCR)OS; 92Poor survival outcomeTNM stage, LNM, tumor sizeDiagnosis/prognosis[26]
LINC01123RNA-seq, FISH, RT-qPCRNSCLC tissues; 3 (RNA-seq), 92 (FISH), and 16 (RT-qPCR)OS; 92Poor survival outcomeTNM stage, T stage, LNMDiagnosis/prognosis[31]
HOXA11-ASRT-qPCRLC tissues; 40OS; 40Poor survival outcomeTNM stage, tumor size, LNMDiagnosis/prognosis[33]
ABHD11-AS1RT-qPCRLC tissues; 40OS; exact number not mentionedPoor survival outcomeTNM stageDiagnosis/prognosis[35]
AL355338FISH, RT-qPCRLC tissues; 80 (RT-qPCR)OS; 80Poor survival outcomeTNM stage, T stage, LNM, distant metastasisDiagnosis/prognosis[36]
HOTAIRM1RT-qPCRNSCLC tissues (exact number not mentioned)Diagnosis[37]
LINC01537RNA-seqLC tissues; 8Prognostic score in the TCGA LC cohortBetter survival outcomePrognosis[38]
ARHGAP10FISHLC tissues; 92OS; exact number not mentionedPoor survival outcomePrognosis[19]
circMYLKRT-qPCRLC tissues; 103OS; 103Poor survival outcomeTNM stage, tumor sizeDiagnosis/prognosis[20]
circ_0008928RT-qPCRSerum exosomes; 28 from cisplatin-sensitive NSCLC patients and 19 from cisplatin-resistant NSCLC patientsDiagnosis[21]
circMAGI3RT-qPCRLC tissues; 30OS; exact number not mentionedPoor survival outcomeTNM stageDiagnosis/prognosis[24]
circAGFG1RT-qPCRNSCLC tissues and corresponding serum samples; 45OS; 45Poor survival outcomeDiagnosis/prognosis[29]
circSLC25A16RT-qPCRNSCLC tissues; 40OS; exact number not mentionedPoor survival outcomeTNM stageDiagnosis/prognosis[30]
circ-MEMO1RT-qPCRNSCLC tissues; 52OS; 52Poor survival outcomeClinical stage, LNMDiagnosis/prognosis[32]
circDCUN1D4ISHNSCLC tissues; 92OS; exact number not mentionedBetter survival outcomeTNM stageDiagnosis/prognosis[39]
circ-ERBB2RT-qPCRLC tissues; 31Diagnosis[40]
circTADA2ART-qPCRLC tissues; 30Diagnosis[41]
circ-PGCRT-qPCRNSCLC tissues; 33OS; exact number not mentionedPoor survival outcomeTNM stage, tumor size, LNMDiagnosis/prognosis[42]
circPUM1RT-qPCRNSCLC tissues; 62OS; 62Poor survival outcomeTNM stageDiagnosis/prognosis[43]
circ_0000517RT-qPCRNSCLC tissues; 60OS; 60Poor survival outcomeTNM stage, LNMDiagnosis/prognosis[44]
circ-PITX1RT-qPCRNSCLC tissues; 41Diagnosis[45]
circ_0006677RT-qPCRNSCLC tissues; 88OS; 88Better survival outcomeTNM stage, tumor size, LNMDiagnosis/prognosis[46]
circNFIXRT-qPCRNSCLC tissues; 55OS; 55Poor survival outcomeTNM stage, distant metastasisDiagnosis/prognosis[47]
circ-ENO1RT-qPCRLC tissues; 64Diagnosis[48]
CTD-2245E15.3RT-qPCRNSCLC tissues from TCGA database; 535Diagnosis[49]
CCAT1ISH, RT-qPCRLC tissues; 10OS/DFS, 504Poor survival outcomeClinical stageDiagnosis/prognosis[50]
circ-LDLRAD3RT-qPCRNSCLC tissues; 60TNM stage; LNMDiagnosis[52]
MINCRRT-qPCRNSCLC tissues; 35OS; exact number not mentionedPoor survival outcomeDiagnosis/prognosis[53]
lncRNA-PVT1-5RT-qPCRLC tissues; 80Diagnosis[51]
circ_0003028RT-qPCRNSCLC tissues; 53Diagnosis[55]